556 results match your criteria: "Clinical Nutrition and Metabolism[Affiliation]"

Assessment and management of frailty in individuals living with dementia: expert recommendations for clinical practice.

Lancet Healthy Longev

December 2024

Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Stavanger, Norway; Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.

Frailty complicates the care of individuals with dementia, increasing their vulnerability to adverse outcomes. This Personal View presents expert recommendations for managing frailty in individuals with dementia, aimed at health-care providers, particularly those in primary care. We conducted a rapid literature review followed by a consensus process involving 18 international experts on dementia and frailty.

View Article and Find Full Text PDF

Many older adults who are certified for long-term care services live or stay in long-term care facilities (LTCFs), where they receive medical and nursing care. These individuals often encounter medication-related problems, such as polypharmacy and complex medication regimens, including frequent administration schedules. Although considerable attention has been paid to polypharmacy in the context of optimizing medication use in older adults, little emphasis has been placed on simplifying these regimens.

View Article and Find Full Text PDF
Article Synopsis
  • The study explored how levels of omega-3 and omega-6 polyunsaturated fatty acids (PUFA) in the blood affect the risk of developing allergic diseases, like rhinitis, from childhood through young adulthood.
  • The research involved 933 participants from the BAMSE cohort, analyzing PUFA levels at ages 8 and 16, and assessing their association with allergic reactions by age 24.
  • Findings indicated that higher levels of certain PUFA, particularly omega-3 and arachidonic acid, at age 8 were linked to lower risks of rhinitis and allergic sensitization; however, these relationships might be influenced by pre-existing conditions in childhood rather than new cases that develop later.
View Article and Find Full Text PDF

Blood biomarkers of trans-fatty acid intake among Nigerian adults in the Federal Capital Territory: a cross-sectional study.

Am J Clin Nutr

January 2025

Cardiovascular Research Unit, University of Abuja, and University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria; Department of Internal Medicine, Faculty of Clinical Sciences, University of Abuja, Abuja, Nigeria.

Background: Intake of trans-fatty acids (TFAs) is an established risk factor for cardiovascular disease. In April 2023, Nigeria passed regulations limiting TFA content in foods, fats, and oils, but the current level of TFA exposure in the Nigerian population is unknown.

Objectives: To quantify trans-fatty acid (TFA) biomarkers in dried blood spots from Nigerian adults in the Federal Capital Territory before policy enforcement, establish baseline levels for future evaluations, assess subgroup variations by demographic and socioeconomic factors, and compare TFA levels with data from 30 countries worldwide.

View Article and Find Full Text PDF

Estimated health effect, cost, and cost-effectiveness of mandating sodium benchmarks in Australia's packaged foods: a modelling study.

Lancet Public Health

November 2024

The George Institute for Global Health, Faculty of Medicine, UNSW Sydney, Sydney, NSW, Australia; School of Population Health, UNSW Sydney, Sydney, NSW, Australia.

Background: Excess dietary sodium is a leading cause of death and disability globally. Because packaged foods are a major source of sodium in many countries, including Australia, mandatory limits for sodium might improve population health. We aimed to estimate the long-term health and economic effect of mandating such thresholds in Australia.

View Article and Find Full Text PDF
Article Synopsis
  • Excessive saturated fatty acids (SFAs) negatively impact health, but their relationship with thyroid hormones has been underexplored.
  • A study using data from 579 participants revealed significant differences in thyroid stimulating hormone (TSH) levels associated with nine specific SFAs, indicating complex interactions between SFAs and thyroid parameters.
  • Results showed both positive and negative correlations between specific SFAs and various thyroid-related measures, emphasizing the importance for further research to understand these connections better.
View Article and Find Full Text PDF
Article Synopsis
  • Pegvaliase is a therapy for phenylketonuria (PKU) that helps patients manage blood phenylalanine levels without strict diets, leading to a focus on promoting the Mediterranean diet during nutritional counseling.
  • A study evaluated seven PKU patients on Pegvaliase to assess their adherence to the Mediterranean diet and the adequacy of their nutrient intake, finding general adherence similar to the population but issues with excessive sugar and inadequate micronutrients like zinc and iron.
  • The results suggest that regular nutritional counseling helps these patients adopt healthier eating habits compared to the general population, but further improvements are needed in achieving a balanced diet.
View Article and Find Full Text PDF
Article Synopsis
  • Elderly patients often face feeding and swallowing issues, leading to the use of the simple suspension method where tablets are dissolved in warm water for tube administration without crushing.
  • A study using verapamil revealed that drug release was faster from crushed tablets than from the simple suspension or intact tablets, indicating significant differences in dissolution profiles.
  • While both crushing and simple suspension methods can safely help patients with dysphagia, they may also increase the risk of side effects, so it's advisable to avoid altering medications before giving them.
View Article and Find Full Text PDF

Editorial: Inflammation and Not Glucocorticoid Therapy is the Key Driver of Fracture Risk in IBD.

Aliment Pharmacol Ther

December 2024

Clinical Nutrition and Metabolism Unit, Monash Health, Melbourne, Victoria, Australia.

View Article and Find Full Text PDF

Reply to P Yang et al.

Am J Clin Nutr

October 2024

From the Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden. Electronic address:

View Article and Find Full Text PDF

A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity.

Eat Behav

December 2024

Department of Medical and Surgical Sciences, University of Bologna, Via Zamboni, 33, Bologna 40126, Italy; Clinical Nutrition and Metabolism Unit, IRCCS AOUBO, Via Albertoni, 15, Bologna 40138, Italy.

Liver transplantation (LT) associates with weight gain and metabolic complications. However, risk of eating disorders post-transplantation and factors influencing their onset remain poorly understood. This study aimed to fill this knowledge gap by characterizing the risk of having eating disorders or Orthorexia Nervosa (ON) according to the EAT-26, BES and Bratman screening questionnaires in 104 liver transplant recipients (mean age 62.

View Article and Find Full Text PDF

Feeding and eating disorders in children and adolescents during the COVID-19 pandemic: real-word data from an observational, naturalistic study.

Minerva Pediatr (Torino)

September 2024

IRCCS Institute of Neurological Sciences, Unit of Pediatric Neuropsychiatry, Centro Regionale per i Disturbi della Nutrizione e dell'Alimentazione in Età Evolutiva, Bologna, Italy -

Article Synopsis
  • The COVID-19 pandemic significantly affected the mental health of children and adolescents, particularly those with feeding and eating disorders (FED), with a notable increase in new cases during the pandemic.
  • A study compared two groups of patients with FED from before and during the pandemic, revealing a 33.7% rise in the number of cases and an increased percentage of females affected.
  • The research showed increased physical hyperactivity and suicidal behaviors among young patients, while fewer individuals required hospitalization, indicating a shift in treatment needs.
View Article and Find Full Text PDF

Metabolic dysfunction-associated steatotic liver disease (MASLD)-and its worse form, metabolic-associated steatohepatitis (MASH), characterised by inflammation and liver damage-corresponds to the liver's involvement in metabolic syndrome, which constitutes an economic burden for healthcare systems. However, the biomolecular pathways that contribute to steatotic liver disease are not completely clear. Abnormalities of bone metabolism are frequent in people affected by metabolic liver disease, with reduced bone density and an increased risk of fracture.

View Article and Find Full Text PDF

The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus.

Metabolism

December 2024

MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Key Laboratory of Diagnosis and Treatment for the Development of Chronic Liver Disease in Zhejiang Province, Wenzhou, China. Electronic address:

Article Synopsis
  • Metabolic dysfunction-associated fatty liver disease (MAFLD) is a rising cause of chronic liver disease globally, prompting the need for dietary intervention strategies.
  • A panel of 55 international experts conducted a study to reach a consensus on dietary modifications for preventing MAFLD, covering various aspects from epidemiology to management.
  • Recommended strategies include following a balanced diet, increasing whole grains and plant-based foods, and reducing red meat and processed foods, along with advocating for physical activity and possibly maintaining Mediterranean or DASH diets.
View Article and Find Full Text PDF

Plasma n6 polyunsaturated fatty acid levels and risk for total and cause-specific mortality: A prospective observational study from the UK Biobank.

Am J Clin Nutr

October 2024

The George Institute for Global Health, Faculty of Medicine and Health, University of New South Wales, Australia; The School of Population Health, UNSW Sydney, Sydney, Australia; Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden; The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.

Article Synopsis
  • The study investigates the relationship between different types of n-6 polyunsaturated fatty acids (PUFAs), especially linoleic acid (LA), and mortality rates from various causes in a large UK Biobank cohort of over 257,000 individuals.
  • Findings indicate that higher levels of LA are linked to reduced total mortality risk, while higher levels of non-LA n-6 PUFAs are associated with increased mortality risk, particularly from non-cardiovascular and non-cancer causes.
  • The research emphasizes that LA and non-LA n-6 PUFAs should not be treated the same when evaluating health impacts, highlighting the importance of maintaining or increasing LA intake for better health outcomes.
View Article and Find Full Text PDF

Inherited metabolic disorders (IMDs), previously considered as a paediatric sub-specialisation are more and more prevalent in adults, thanks to improved survival, and the expansion of diagnostic tools detecting attenuated-late onset forms in adulthood. Italy is one of the countries with the highest number of IMDs screened by dry blood spots in neonates, allowing them to receive early treatments and to reach adult age. Despite this, awareness of IMDs is still low by the adult medical community, with difficulties in transition and transfer of patients to adult services and unmet patient needs.

View Article and Find Full Text PDF

As clinicians involved in the care of patients with disorders of gut-brain interaction (DGBIs), we-and many colleagues-have the impression that social media are adversely shaping the nature, presentation, and ability to manage these disorders, especially at the severe end of the DGBI clinical spectrum. We turned to the research literature to see if these clinical impressions were corroborated but found it virtually nonexistent. Social media have rapidly become a ubiquitous, pervasive part of the lives of most people on the planet.

View Article and Find Full Text PDF

Purpose: This study aimed to comprehensively report the epidemiological and clinical features of atypical anorexia nervosa (AAN) in children and adolescents.

Methods: In May 2024, a systematic review was performed using Medline, Cochrane Library, ClinicalTrials.gov, and relevant websites.

View Article and Find Full Text PDF

Current cardiometabolic disease prevention guidelines recommend increasing dietary unsaturated fat intake while reducing saturated fats. Here we use lipidomics data from a randomized controlled dietary intervention trial to construct a multilipid score (MLS), summarizing the effects of replacing saturated fat with unsaturated fat on 45 lipid metabolite concentrations. In the EPIC-Potsdam cohort, a difference in the MLS, reflecting better dietary fat quality, was associated with a significant reduction in the incidence of cardiovascular disease (-32%; 95% confidence interval (95% CI): -21% to -42%) and type 2 diabetes (-26%; 95% CI: -15% to -35%).

View Article and Find Full Text PDF

Response to review by Pan et al.

Obesity (Silver Spring)

September 2024

Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.

View Article and Find Full Text PDF

Malnutrition in Adults.

N Engl J Med

July 2024

From Clinical Nutrition and Metabolism, Department of Public Health and Caring Sciences, Uppsala University, Uppsala (T.C.), Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm (T.C.), Theme Inflammation and Aging, Medical Unit Aging, Karolinska University Hospital, Stockholm (T.C.), and the Department of Internal Medicine and Clinical Nutrition, University of Gothenburg, Gothenburg, and the Clinical Nutrition Unit, Sahlgrenska University Hospital, Gothenburg (I.B.) - all in Sweden.

View Article and Find Full Text PDF
Article Synopsis
  • The FDA approved resmetirom as the first drug for treating non-alcoholic steatohepatitis (NASH) with fibrosis on March 14, 2024, after over 25 years of research and challenges.
  • The drug is intended to work alongside lifestyle changes, which have been the only approved treatment for this condition until now.
  • Important questions arise about trial continuation, appropriate community use, managing coexisting health issues, and ensuring cost-effectiveness to avoid disparities in treatment access.
View Article and Find Full Text PDF